%0 Journal Article
%T Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review
%A Lisa Matricciani
%A Kerwin Talbot
%A Sara Jones
%J Journal of Foot and Ankle Research
%D 2011
%I BioMed Central
%R 10.1186/1757-1146-4-26
%X The question for this systemic review was: 'what evidence is there for the safety and/or efficacy of all treatment interventions for adults with tinea pedis and/or onychomycosis in people with diabetes'? A systematic literature search of four electronic databases (Scopus, EbscoHost, Ovid, Web of Science) was undertaken (6/1/11). The primary outcome measure for safety was self-reported adverse events likely to be drug-related, while the primary outcome measures assessed for 'efficacy' were mycological, clinical and complete cure.The systematic review identified six studies that examined the safety and/or efficacy of treatment interventions for onychomycosis in people with diabetes. No studies were identified that examined treatment for tinea pedis. Of the studies identified, two were randomised controlled trials (RCTs) and four were case series. Based on the best available evidence identified, it can be suggested that oral terbinafine is as safe and effective as oral itraconazole therapy for the treatment of onychomycosis in people with diabetes. However, efficacy results were found to be poor.This review indicates that there is good evidence (Level II) to suggest oral terbinafine is as safe and effective as itraconazole therapy for the treatment of onychomycosis in people with diabetes. Further research is needed to establish the evidence for other treatment modalities and treatment for tinea pedis for people with diabetes. Future efforts are needed to improve the efficacy of treatment intervention.Diabetes affects approximately 285 million people worldwide, with estimates expected to rise to 438 million in 2030 [1]. Diabetes is associated with a number of serious and costly health complications, in particular, diabetic foot ulcers [2,3]. Foot ulcers cause considerable disability [4,5], morbidity [6] and are the leading cause of foot amputations and hospitalisations among people with diabetes [7-11]. While measures such as foot care and patient education are acknowl
%K Onychomycosis
%K tinea pedis
%K diabetes
%K treatment
%K safety
%K efficacy
%U http://www.jfootankleres.com/content/4/1/26